Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study

Leuk Lymphoma. 2020 Jun;61(6):1435-1444. doi: 10.1080/10428194.2020.1719092. Epub 2020 Feb 7.

Abstract

Richter's transformation (RT) refers to the development of an aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL). Approximately, 2-10% of patients with CLL develop RT, most often as diffuse large B-cell lymphoma. To assess the incidence of RT, we examined risk factors for RT and death among patients with RT in a nationwide CLL cohort (from 2008 to 2016). Among 3772 patients, 113 had biopsy-proven RT. With a median follow-up of 4.3 years, the 5-year cumulative incidence of RT was 2.8%. Advanced Binet stage (B/C) (p<.001), unmutated IGHV (p<.001), and del(17p) (p<.001) were independently associated with risk of developing RT. Half of the patients with RT (49%) were treatment-naïve prior to transformation and demonstrated longer survival after RT compared to patients previously treated for CLL (6.1 vs. 2.8 years, p=.03). Whether this finding could be explained by a higher proportion of clonally unrelated RT among treatment-naïve patients, remain to be addressed.

Keywords: Chronic lymphocytic leukemia; Hodgkin lymphoma; Richter’s transformation; diffuse large B-cell lymphoma; prognostication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Cell Transformation, Neoplastic
  • Epidemiologic Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / epidemiology
  • Lymphoma, Large B-Cell, Diffuse* / epidemiology